WHO ICTRP trial
Examination of the efficacy and safety of Doripenem for hospital-aquired…
JPRN-UMIN000004408 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000004408 |
|---|---|
| Public title | Examination of the efficacy and safety of Doripenem for hospital-aquired pneumonia |
| Scientific title | Examination of the efficacy and safety of Doripenem for hospital-aquired pneumonia - Examination of the efficacy and safety of Doripenem |
| Primary sponsor | Hamamatsu University |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase IV |
| Countries | Japan |
| Conditions | Hospital-acquired pneumonia patient |
| Interventions | we treat with 0.5g of Doripenem for an hour or more and it is intravenous dripped three times a day. If the improvement is obtained, the antibiotics administering is ended. If the improvement is not obtained, the antibiotics is probably… |
| Registration date | Jan 11, 2010 |
| Target size | 80 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: